Strategic Intent: Understanding Crossover Strategies in Biotech With Sofinnova Partners’ David Evans

In this episode of Strategic Intent, Partner at Sofinnova Partners, David Evans discusses his transition from Roche Venture Fund, different investments strategies, general market analysis across Europe and US, as well as growing therapeutics area trends within biotech.